Aclaris Therapeutics Inc —— 现金流量表 (NASDAQ:ACRS) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 -38.63 M-52.13 M-67.57 M-78.33 M-20.07 M-47.11 M -47.11 M 投资活动产生的现金 6.39 M-167.63 M12.63 M46.22 M-69.77 M48.37 M 48.37 M 融资活动产生的现金 18.37 M225.05 M72.87 M26.71 M74.54 M-5.86 M -5.86 M 自由现金流 -39.09 M-52.44 M-68.17 M-79.63 M-56.01 M-47.22 M -48.06 M

新闻

Profound Medical (PROF) Surges 13.0%: Is This an Indication of Further Gains?

H.C. Wainwright维持Aclaris Therapeutics买入评级

Aclaris Therapeutics stock rating reiterated at Buy by H.C. Wainwright

Stifel因管线前景上调Aclaris Therapeutics目标价至3美元

Stifel raises Aclaris Therapeutics stock price target to $3 on pipeline

Aclaris Therapeutics (ACRS) Reports Q4 Loss, Lags Revenue Estimates

Aclaris TherapeuticsQ4每股收益及营收逊于预期

Aclaris Therapeutics Inc earnings missed by $0.01, revenue fell short of estimates

Ionis Pharmaceuticals (IONS) Reports Q4 Loss, Tops Revenue Estimates

Corcept Therapeutics (CORT) Q4 Earnings and Revenues Miss Estimates

Aclaris启动ATI-052治疗哮喘患者的1b期试验

Aclaris starts phase 1b trial of ATI-052 in asthma patients